Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial

Firdausi Qadri, Marjahan Akhtar, Taufiqur R. Bhuiyan, Mohiul I. Chowdhury, Tasnuva Ahmed, Tanzeem A. Rafique, Arifuzzaman Khan, Sadia I.A. Rahman, Farhana Khanam, Anna Lundgren, Gudrun Wiklund, Joanna Kaim, Madeleine Löfstrand, Nils Carlin, A. Louis Bourgeois, Nicole Maier, Alan Fix, Thomas Wierzba, Richard I. Walker, Ann Mari Svennerholm

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences